Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06500494 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of Treatment

Study acronym: VINOREAL
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Feb 2028 to Sep 2028 Trial status: Recruiting to Active, Not Recruiting · Site details revised at 3 of 3 sitesv4 Show 2 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 3 of 3 sites
  2. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Sep 2026 to Feb 2028 · Study sites: 0 to 3 · Completion date: Dec 2027 to Feb 2028 · 1 morev3 Show 4 more changesShow less
    • Primary completion date: Sep 2026 to Feb 2028
    • Study sites: 0 to 3
    • Completion date: Dec 2027 to Feb 2028
    • Start date changed from estimate of Sep 2024 to Sep 10, 2024
  3. Eligibility criteria shortened, about 33 wordsv2 See this version in full on ClinicalTrials.gov ↗
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study looks at how well oral vinorelbine works in treating advanced breast cancer. It looks at women who have already had this treatment or are currently having it.
Trial Details
NCT Number NCT06500494
Lead Sponsor Pierre Fabre Medicament
Conditions Advanced Breast Cancer
Enrollment 368 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov